Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8649540 | Cardiovascular Revascularization Medicine | 2017 | 9 Pages |
Abstract
Development of membranous ventricular septal defects (VSD) is a rare complication of transcatheter aortic valve replacements (TAVR), and is recognized using intraoperative and postoperative imaging. We present two cases of this rare but serious complication; one was successfully managed conservatively and the other with valve-in-valve therapy. Management strategies for post-TAVR VSDs varies, but should be individualized to the clinical scenario. We performed a literature search and sought to identify various risk factors which may predispose patients to the development of VSD after TAVR.
Keywords
STSCVATHVVSDTAVRTEEMSCTLVOTtransesophageal echocardiogramcoronary artery diseasechronic kidney diseaseVentricular tachycardiaTranscatheter aortic valve replacementAortic stenosisSociety of Thoracic Surgeonstranscatheter heart valveCerebrovascular accidentCADleft ventricular outflow tractCKDVentricular septal defect
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
M. Rizwan Sardar, Zubair A. Khan, Anu Abraham, Wajeeha Saeed, Muhammad Farhan, Dhaval Kolte, Barry Sharaf, Paul Gordon, Frank Sellke, Neel R. Sodha, Herbert D. Aronow, Afshin Ehsan,